Heraeus Singapore expands into medical materials

SINGAPORE -- Heraeus announces the opening of a new Singapore facility to support expansion of their Medical Components Division. This Singapore expansion is focused on R&D and production of Materials and Components for the medical device industry. This facility will increase Heraeus' presence in Asia to more than 20 manufacturing facilities.

Singapore was selected as the new Medical Materials Development and Production Center in Asia for a number of reasons, said Dr Nicolas Guggenheim, president of Heraeus' Medical Components Division.

"Heraeus has a long tradition of being close to our customers and there has been a strong movement in the last few years by our major Cardiac Rhythm Management customers to relocate their medical device manufacturing to Southeast Asia. With the strong Asian investment in local startups, a strong base of new Asian medical device companies is growing in the region, which makes for a powerful mix of companies and innovation."

Singapore is uniquely positioned as a premier high-tech hub providing access to a very technical and well educated workforce that can support our development efforts. "Being the first phase of Heraeus Medical Components' Asian operations strategy, Singapore's ideal location situated between Malaysia and Indonesia provides both Heraeus and our customers with nearby lower cost manufacturing and production options," said Dr Guggenheim.

Mark Kempf, executive vice-president of Global Business Lines, said Heraeus Medical Components is also very fortunate to be able to leverage the existing Heraeus Singapore infrastructure, which includes one of the world's largest bonding wire facilities and that has already received approval by many of the division’s top medical customers.